Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 22 January 2026

AI stocks today: Intel earnings, Nvidia export vote and rising memory prices in focus

AI stocks today: Intel earnings, Nvidia export vote and rising memory prices in focus

Intel jumped 11.7% to $54.25 Wednesday, leading gains among AI chipmakers ahead of its quarterly report; Nvidia rose 3%, AMD 7.6%, and Micron 6.6%. Compal warned memory costs could reach up to 40% of PC component prices due to surging demand. The U.S. House advanced a bill to tighten AI chip exports, targeting Nvidia’s Blackwell chips. The S&P 500 rose 1.16% after Trump’s Greenland deal and tariff pause.
22 January 2026
·········
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex Pharmaceuticals shares rose 4.31% to $461.14, extending gains for a third session with trading volume above the 50-day average. The company will report fourth-quarter and full-year 2025 results after the U.S. market closes on Feb. 12, followed by a conference call. Director Bruce I. Sachs received 107.088 deferred stock units, according to a Jan. 15 regulatory filing.
22 January 2026
···
Capital One stock price ticks up ahead of earnings as 10% rate-cap talk shadows card lenders

Capital One stock price ticks up ahead of earnings as 10% rate-cap talk shadows card lenders

Capital One shares rose 1% to $231.01 Wednesday ahead of its fourth-quarter earnings report due after Thursday’s close. Investors remain focused on possible U.S. credit card rate caps, with President Trump pushing Congress for a 10% limit. HSBC cut its price target to $226, while Morgan Stanley raised its target to $300. The Discover merger and credit quality remain in focus as traders await management’s comments.
22 January 2026
··
Freeport-McMoRan stock nudges higher into earnings as copper steadies — what to watch Thursday

Freeport-McMoRan stock nudges higher into earnings as copper steadies — what to watch Thursday

Freeport-McMoRan shares closed up 0.9% at $60.58 Wednesday ahead of its quarterly earnings report due before Thursday’s open. Copper prices rose 0.4% to $12,796 a ton on the LME, but the Yangshan premium fell to its lowest in 18 months, signaling weak Chinese demand. Analysts expect Freeport to report EPS of $0.32 on $5.35 billion in revenue.
22 January 2026
··
Seagate (STX) stock jumps 6% after a fresh BNP upgrade — what traders are watching into earnings

Seagate (STX) stock jumps 6% after a fresh BNP upgrade — what traders are watching into earnings

Seagate shares rose 5.6% to $344.22 in after-hours trading Wednesday after BNP Paribas upgraded the stock and Citi and BofA raised price targets. The moves come ahead of Seagate’s fiscal Q2 earnings report, set for release January 27. Trading volume reached 4.7 million shares, with prices ranging from $324.06 to $349.90 during the session.
22 January 2026
···
AbbVie stock rises after-hours as Bernstein sticks with $225 target ahead of Feb. 4 earnings

AbbVie stock rises after-hours as Bernstein sticks with $225 target ahead of Feb. 4 earnings

AbbVie shares closed up 0.99% at $216.15 Wednesday, trading near typical volume ahead of its Feb. 4 earnings report. Bernstein’s Courtney Breen maintained a Market Perform rating and $225 target. Investors are watching for 2026 guidance and updates on AbbVie’s new drug performance. Details of a recent pricing deal with the Trump administration remain undisclosed.
22 January 2026
·
ServiceNow stock price ticks up after hours as OpenAI tie-up and Oppenheimer cut sharpen focus on Jan. 28 earnings

ServiceNow stock price ticks up after hours as OpenAI tie-up and Oppenheimer cut sharpen focus on Jan. 28 earnings

ServiceNow shares rose 0.5% to $125.92 in after-hours trading Wednesday, following a fifth straight day of losses. Oppenheimer cut its price target to $175, citing concerns over recent acquisitions. Investors await Jan. 28 results for updates on AI rollout and integration. ServiceNow and OpenAI announced a multi-year deal to embed GPT-5.2 in ServiceNow workflows.
22 January 2026
····
MercadoLibre stock ticks up after-hours as fresh SEC filing shows $238 mln fund stake — what to watch next (MELI)

MercadoLibre stock ticks up after-hours as fresh SEC filing shows $238 mln fund stake — what to watch next (MELI)

MercadoLibre shares rose about 1% to $2,057.77 in after-hours trading Wednesday, with 943,000 shares traded. A new SEC filing showed Northcape Capital held 116,848 shares worth $238.4 million at the end of 2025. The move came as Wall Street rebounded after tariff concerns eased. MercadoLibre plans to release Q4 results on Feb. 24.
22 January 2026
··
Lumentum stock price extends rally after Aletheia lifts target to $500 ahead of Feb. 3 earnings

Lumentum stock price extends rally after Aletheia lifts target to $500 ahead of Feb. 3 earnings

Lumentum Holdings shares rose 1.6% to $362.44 in after-hours trading Wednesday, after a 10% gain Tuesday. Aletheia Capital raised its price target to $500, citing strong demand for high-speed optical lasers. About 5 million shares traded during the day. Investors await Lumentum’s fiscal Q2 report on Feb. 3 for updates on orders and pricing.
22 January 2026
··
Exxon Mobil stock price jumps to a fresh 52-week high after hours — here’s what investors watch next

Exxon Mobil stock price jumps to a fresh 52-week high after hours — here’s what investors watch next

Exxon Mobil shares rose 2.4% to $133.61 in after-hours trading Wednesday, hitting a new 52-week high on volume of 18.9 million shares. The move followed supply disruptions in Kazakhstan and ahead of U.S. inventory data due Thursday. Brent crude settled at $65.24 a barrel, while U.S. WTI closed at $60.62. Diesel futures jumped 4% as U.S. refineries prepared for an Arctic blast.
22 January 2026
···
1 … 66 67 68 69 70 … 202

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Go toTop